A pivotal month for UBS Group AG is set to culminate in a high-stakes clash with Swiss regulators. The bank’s management, freshly endorsed by shareholders, now faces a dual regulatory threat that could impose tens of billions in new capital requirements and directly threaten its share buyback program.
At the annual general meeting in Basel, shareholders delivered a strong vote of confidence. They approved a dividend increase to $1.10 per share and backed a leadership transition. Markus Ronner will assume the vice chairman role from Lukas Gähwiler, who is retiring after more than four decades in the industry. While other board candidates received support well above 90%, Chairman Colm Kelleher’s approval rating was notably lower at 88%.
Despite this internal harmony, the external conflict is escalating. Kelleher issued a stark warning to the Swiss government, stating that proposed capital rules would seriously endanger the bank’s business model without meaningfully improving financial stability. He explicitly ruled out shrinking the bank and directly linked the future of share repurchases to the outcome of the regulatory dispute.
The immediate pressure comes from two key regulations on a tight timeline. The Swiss Federal Council is poised to publish an ordinance defining what assets UBS must exclude from its CET1 capital. Analysts at Bank of America anticipate some relief, suggesting deferred tax assets could be recognized up to a 10% cap of CET1, aligning with international Basel III standards. In this scenario, the capital hit from rules on intangible assets would fall to $6.2 billion from a current estimate of $10.8 billion.
Yet this potential easing is only one piece of a far heavier package. Concurrently, a second proposal requiring UBS to fully capitalize its foreign subsidiaries with core equity is expected in April, with parliamentary debate to follow in May. The government insists on this full capitalization, a move UBS fiercely opposes. Combined, the original proposals would create an additional capital need of approximately $22 billion. The requirement for the Swiss entity alone, concerning intangible assets, demands a further $3 billion.
Should investors sell immediately? Or is it worth buying UBS?
The backdrop is the state-backed acquisition of Credit Suisse in 2023, which prompted Switzerland to pledge stricter rules for its sole remaining global bank. UBS’s balance sheet is roughly double the size of the entire Swiss economy.
CEO Sergio Ermotti has championed proportionate, internationally coordinated regulation over national solo efforts. The bank is lobbying intensely against the reforms and has reportedly even examined a potential relocation of its headquarters abroad for 2025—a measure Bank of America analysts view as a last resort, with asset sales, possibly of the US business, being a more likely first step.
The political process accelerates on April 22, when the Federal Council votes on the draft capital rules. Market observers expect the government to hold firm on the strict subsidiary capitalization rule. The full legislative process is unlikely to conclude before the end of 2026, leaving room for parliament to potentially dilute the measures.
One week after that political signal, on April 29, UBS will release its first-quarter results. This report will reveal whether the bank has met rising profit expectations and show the true progress in integrating Credit Suisse’s systems. It will also provide the first clear indication of how severely the looming regulatory pressure is dictating the financial outlook for the year ahead.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from April 17 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 17.
UBS: Buy or sell? Read more here...









